Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-12, Stock:NVS, The news for the past five days is as follows:
2019-07-05: NEWS1: The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight.
2019-07-08: NEWS1: Novartis' Struggle With Payers Over Zolgensma Is Overblown.NEWS2: Here's Why Coherus BioSciences Is Falling Today.NEWS3: Here's Why Coherus BioSciences Is Falling Today.
2019-07-09: NEWS1: Novo Nordisk Reports Encouraging Data From Hemophilia Studies.NEWS2: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS3: Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline.NEWS4: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS5: The Fundamental Problems of Tilray Stock Are Just Getting Worse.NEWS6: UPDATE 3-Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage.NEWS7: Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage.
2019-07-10: NEWS1: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.NEWS2: EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce Supply.NEWS3: EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce Supply.NEWS4: How This Novartis Mashup Could Validate A Biotech Company's Cancer Drug.NEWS5: The 10 Biggest Healthcare Stocks.NEWS6: The 10 Biggest Healthcare Stocks.NEWS7: The 10 Biggest Healthcare Stocks.NEWS8: Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset.NEWS9: Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset.NEWS10: EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce Supply.NEWS11: Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset.NEWS12: Here's Why Array BioPharma Soared 75.4% in June.NEWS13: Here's Why Array BioPharma Soared 75.4% in June.NEWS14: Mylan Falls on Report That EpiPen Shortage Is Hurting Patients and Pharmacists.NEWS15: The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV.NEWS16: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS17: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS18: Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline.NEWS19: Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline.NEWS20: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS21: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS22: Novo Nordisk Reports Encouraging Data From Hemophilia Studies.NEWS23: Novo Nordisk Reports Encouraging Data From Hemophilia Studies.
2019-07-11: NEWS1: Amneal (AMRX) Down on Guidance Update & Restructuring Plan.NEWS2: Amneal (AMRX) Down on Guidance Update & Restructuring Plan.NEWS3: Amgen and Novartis drop Alzheimer's-prevention study after patients worsened.NEWS4: Signature Select Canadian Fund's Top 6 Buys.NEWS5: Amneal (AMRX) Down on Guidance Update & Restructuring Plan.NEWS6: Amgen, Novartis abandon two Alzheimer’s drug studies.NEWS7: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.NEWS8: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.

Answer: Decrease